Medical Researches
Possibly Effective
Based on 9 Researches
We evaluated the effectiveness of probiotics, including strains like Lactobacillus rhamnosus and Saccharomyces boulardii, in preventing antibiotic-associated diarrhea (AAD) in children. Our review covered 23 diverse studies involving nearly 4,000 young participants.
The results were promising: probiotics reduced the incidence of AAD from 19% to 8%. While results were generally optimistic, with no serious side effects reported, moderate evidence suggests further studies are needed before fully endorsing probiotics for all pediatric patients.
Read More
Saccharomyces boulardii improves constipationAPPLICATION OF THE SACCHAROMYCES BOULARDII PROBIOTIC COMPLEX IN THE CORRECTION OF INTRAINTESTINAL HOMEOSTASIS IN PATIENTS WITH DYSBIOTIC DISORDERS DUE TO ANTIBIOTIC THERAPY.
Study shows positive clinical outcomes
We examined how Saccharomyces boulardii, a probiotic, can help patients experiencing constipation and other symptoms of dysbiosis. Over a two-year period, 209 patients were treated; those given this probiotic showed significant improvements.
Most reported a reduction in stool frequency and alleviation of discomfort, such as flatulence and abdominal pain. In fact, 92.9% of the 141 patients in the main treatment group experienced a noticeable improvement after the treatment course.
Overall, the findings suggest that Saccharomyces boulardii can effectively enhance intestinal health in individuals affected by gastrointestinal disorders, including constipation.
Read More
We examined the effectiveness of Saccharomyces boulardii as an add-on therapy for treating Helicobacter pylori and its impact on constipation.
Our analysis included 18 trials with over 3,500 patients. The results showed that S. boulardii not only helped boost H. pylori eradication rates but also reduced the incidence of constipation.
Overall, S. boulardii appears beneficial as it increases treatment success while decreasing side effects, making it a promising option for those undergoing H. pylori therapy.
Read More
Probiotics alleviate IBS symptomsEffect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
Highly relevant clinical study
We explored how a mix of probiotics, including Saccharomyces boulardii, impacts symptoms of irritable bowel syndrome (IBS) in patients both with and without small intestinal bacterial overgrowth (SIBO). After treating 26 patients over 30 days, those with SIBO saw a remarkable 71.3% decrease in IBS symptoms, compared to only 10.6% in those without SIBO.
Interestingly, patients with constipation-predominant IBS also experienced significant improvements, highlighting the potential benefits of these probiotics. Overall, our findings suggest probiotics can effectively relieve IBS symptoms, particularly in those with SIBO.
Read More
Supplement reduces therapy side effectsThe effect of supplementing with on bismuth quadruple therapy for eradicating : a systematic review and meta-analysis of randomized controlled trials.
Study identifies important treatment benefits
We investigated whether adding a specific supplement to bismuth quadruple therapy improves infection eradication and reduces side effects. Our analysis of six randomized controlled trials, involving 1,404 patients, showed that while there wasn’t a significant increase in eradication rates, the combination treatment resulted in a notable decrease in adverse effects such as diarrhea, abdominal distention, and constipation. These findings suggest that supplementing with this product alongside standard therapy may enhance patient comfort and encourage adherence to treatment.
Read More